Edges in Network
| Network | GSE25055_egf1520 - GSE25055 - SiGN-BN HC+Bootstrap |
| Network Description | Discovery cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | ACTA2 |
| Upstream (Parents) |
|---|
| (<<) CTGF → ACTA2 |
| (<<) IGFBP3 → ACTA2 |
| (<<) IGFBP7 → ACTA2 |
| (<<) ITGA5 → ACTA2 |
| (<<) MXRA8 → ACTA2 |
| (<<) MYLK → ACTA2 |
| (<<) PRKCDBP → ACTA2 |
| Downstream (Children) |
|---|
| ACTA2 → ACTN4 (>>) |
| ACTA2 → ADAM12 (>>) |
| ACTA2 → AKAP12 (>>) |
| ACTA2 → AKT3 (>>) |
| ACTA2 → CASP9 (>>) |
| ACTA2 → CAV1 (>>) |
| ACTA2 → CDH11 (>>) |
| ACTA2 → CLDN5 (>>) |
| ACTA2 → COL13A1 (>>) |
| ACTA2 → CRCT1 (>>) |
| ACTA2 → CYB5R3 (>>) |
| ACTA2 → CYR61 (>>) |
| ACTA2 → DAB2 (>>) |
| ACTA2 → E2F4 (>>) |
| ACTA2 → EDNRA (>>) |
| ACTA2 → EFEMP1 (>>) |
| ACTA2 → EFEMP2 (>>) |
| ACTA2 → FGF1 (>>) |
| ACTA2 → FGF7 (>>) |
| ACTA2 → FOS (>>) |
| ACTA2 → FUT2 (>>) |
| ACTA2 → GALR3 (>>) |
| ACTA2 → GNG11 (>>) |
| ACTA2 → HOPX (>>) |
| ACTA2 → INHBA (>>) |
| ACTA2 → ISLR (>>) |
| ACTA2 → ITGAV (>>) |
| ACTA2 → KCTD12 (>>) |
| ACTA2 → KIAA1199 (>>) |
| ACTA2 → KRAS (>>) |
| ACTA2 → KRT14 (>>) |
| ACTA2 → MLX (>>) |
| ACTA2 → MMP10 (>>) |
| ACTA2 → MMP14 (>>) |
| ACTA2 → MMP2 (>>) |
| ACTA2 → MMP3 (>>) |
| ACTA2 → MT1P2 (>>) |
| ACTA2 → MYL9 (>>) |
| ACTA2 → NBL1 (>>) |
| ACTA2 → NDOR1 (>>) |
| ACTA2 → NGFR (>>) |
| ACTA2 → NNMT (>>) |
| ACTA2 → PAK1 (>>) |
| ACTA2 → PCSK7 (>>) |
| ACTA2 → PELO (>>) |
| ACTA2 → PIK3R3 (>>) |
| ACTA2 → PLAU (>>) |
| ACTA2 → PPAP2A (>>) |
| ACTA2 → PPP1R3D (>>) |
| ACTA2 → PTRF (>>) |
| ACTA2 → SCG5 (>>) |
| ACTA2 → SMARCC2 (>>) |
| ACTA2 → SOX17 (>>) |
| ACTA2 → STK11 (>>) |
| ACTA2 → SULF1 (>>) |
| ACTA2 → TCF4 (>>) |
| ACTA2 → THRA (>>) |
| ACTA2 → THY1 (>>) |
| ACTA2 → TNC (>>) |
| ACTA2 → TPM2 (>>) |
| ACTA2 → VEGFC (>>) |
